← Back to all trials
Recruiting
NCT07821190
MDW as a Novel Diagnostic Biomarker in LONS Among Preterm Neonates
Conditions: Late Onset Neonatal Sepsis
Sex: All
Ages: 73 Hours – 28 Days
Enrollment: 60
Sponsor: Tanta University
Location: Faculty of Medicine, Tanta University Tanta
Summary
This study aims to evaluate the diagnostic accuracy of monocyte distribution width (MDW) as a novel biomarker for late-onset neonatal sepsis in preterm neonates and to assess its association with disease severity and short-term clinical outcomes
Eligibility Criteria
Inclusion Criteria:The study will include:
1. Preterm neonates with gestational age \72 hours of life at the time of enrollment.
3. Neonates with clinical suspicion of late-onset neonatal sepsis, defined by the presence of one or more of the following:
* Temperature instability (core temperature \>38°C or \
Source: ClinicalTrials.gov (NCT07821190). StuddyBuddy aggregates publicly available trial information.
